20000+ patients trust LaSara

Treatment Guided by LaSara Physicians

Hypospray Tirzepatide Transdermal Delivery

Weight Loss

Say goodbye to needles, say hello to GLP-1 delivered through the skin.

Tirzepatide is a dual-action GLP-1 and GIP treatment designed to help suppress appetite, reduce cravings, improve portion control, and support meaningful weight loss when used with proper dosing and physician guidance.

Whether you are brand new to tirzepatide or currently using a GLP-1 injection, LaSara’s medical providers will review your history, current dose, weight-loss goals, and treatment response to create the right Hypospray protocol for you. For new patients, this may mean starting with an introductory dose and increasing gradually. For patients already on a GLP-1, your provider may recommend a Hypospray protocol that is equivalent to your current dose or, when clinically appropriate, a higher-dose protocol to help support continued progress.

At LaSara, we have had patients lose up to 36 pounds in only 3 months while following a structured tirzepatide treatment plan with consistent use, nutrition support, and medical oversight.

If needles have kept you from starting a GLP-1, Hypospray Tirzepatide may be the newest and most convenient option for helping you reach your weight-loss goals. This needle-free spray is delivered through the skin and designed to make GLP-1 treatment easier, more comfortable, and easier to stay consistent with.

This product works best with consistent use when combined with a healthy diet.

Most users see peak results at 8-12 weeks. The goal is to lose between 1-3 pounds per week.

Months

$399.00

Cancel or pause anytime
Customer support available at every step

Hypospray Tirzepatide uses advanced transdermal delivery technology to administer tirzepatide through the skin instead of through a needle. The medication is delivered as a metered spray, where the formulation is designed to absorb through the skin barrier and enter the body over time.

Published research describes transdermal drug delivery systems as a “non-invasive route for sustained systemic or localized drug delivery” and notes that these systems may help bypass first-pass metabolism and support patient compliance.

With our Hypospray formulation of tirzepatide, the goal is to provide a needle-free delivery method with bioavailability designed to be comparable to injectable delivery, without the stress, discomfort, or hesitation that can come with needles.

Tirzepatide is highly effective for weight loss because it works on two important metabolic pathways: GLP-1 and GIP. These pathways help regulate appetite, hunger signals, fullness, food cravings, insulin response, and how the body manages energy.

When used consistently and guided by a physician, tirzepatide can help patients eat less, feel full sooner, reduce “food noise,” and stay more consistent with a weight-loss plan.

Unlike a once-weekly injection, Hypospray Tirzepatide spreads the weekly-equivalent dose across five weekday applications. Many patients prefer this because it creates a simple daily rhythm and may feel more consistent throughout the week.

Each week, the goal is to receive the same standard weekly dose that would typically come from an injection. With Hypospray, that weekly-equivalent dose is spread across five separate dosing days using a prescribed number of sprays.

Patients apply their dose once daily:

  • Monday
  • Tuesday
  • Wednesday
  • Thursday
  • FridayPatients take Saturday and Sunday off.

    Your provider will prescribe the correct number of sprays based on your treatment plan and weekly tirzepatide-equivalent dose. Follow the directions written on your prescription exactly.

Hypospray Tirzepatide may be a great fit if you want the benefits of a GLP-1 treatment but have been hesitant to start because of needles.

This option was designed for patients who want a simpler, more comfortable way to begin treatment while still receiving physician-guided weight-loss support. If you struggle with appetite, cravings, food noise, late-night snacking, emotional eating, or feeling out of control around food, tirzepatide may help you feel more in control of your hunger and your choices.

Hypospray Tirzepatide may be especially appealing if you want a needle-free GLP-1 option, prefer a simple weekday routine, or have avoided injections in the past.

A LaSara provider will review your health history, current medications, weight-loss goals, and treatment eligibility to determine whether Hypospray Tirzepatide is right for you.

LaSara sources Tirzepatide Hypospray directly from LegitScript-certified compounding pharmacies and from the creators of HypoSpray technology.

We set the standard for quality, consistency, and transparency in the industry. When you receive your medication through LaSara, you know exactly what you are receiving, where it came from, and that your treatment plan is being guided by a licensed medical team.

Our goal is to make advanced weight-loss treatment more accessible without compromising medical oversight. Every patient is supported by LaSara’s care team, and every protocol is selected based on the patient’s needs, goals, tolerability, and provider guidance.

Tirzepatide is a double-action GLP-1 and GIP treatment designed to support appetite control, fullness, and meaningful weight-loss results.

GLP-1 is a hormone pathway involved in appetite control, fullness, digestion, and blood sugar regulation. By activating this pathway, tirzepatide may help patients feel less hungry, get full faster, reduce cravings, and stay more consistent with a healthier eating plan.

GIP is another hormone pathway involved in metabolic function, insulin response, and how the body processes nutrients. Tirzepatide works on both GLP-1 and GIP pathways, which is why it is often described as a dual-action treatment that may provide strong appetite and metabolic support.

Patient Testimonials

What's Inside & Why It Works

One Protocol Hits Two Receptors. Clinically Superior Results.

01

Mechanism 1: GLP-1 Agonism

GLP-1 receptor activation: Signals satiety to the brain, slows gastric emptying, and triggers the right insulin response after meals. Appetite drops and blood sugar stabilizes. The foundation of every GLP-1 result.

02

Mechanism 2: GIP Agonism

GIP receptor activation: Works in parallel to enhance insulin sensitivity and directly support fat cell metabolism. When both pathways fire at once, the body becomes measurably more efficient at burning fat and resisting the hormonal patterns that cause weight loss to stall. This is what separates Tirzepatide from everything else available today.

Frequently Asked Questions

Tirzepatide can be highly effective for patients who use it consistently and follow a medically guided plan. It helps reduce appetite, improve fullness, decrease cravings, and support better portion control.

At LaSara, we have had patients lose up to 36 pounds in 3 months when combining tirzepatide treatment with nutrition, consistency, and provider guidance. Results vary by patient and depend on starting weight, dose, adherence, lifestyle habits, and individual response.

Once you reach your goal weight, your provider may recommend adjusting your dose, transitioning into a maintenance protocol, or creating a plan to help you maintain your results.

The goal is not just to lose weight, but to help you keep it off safely and sustainably. Your LaSara provider will help determine the right long-term strategy based on your progress, appetite, lifestyle habits, labs if needed, and overall health goals.

Hypospray Tirzepatide is designed to deliver a weekly tirzepatide-equivalent dose through the skin without the need for a needle. Our Hypospray formulation of tirzepatide is designed to support bioavailability comparable to injectable delivery while giving patients a more comfortable and convenient treatment experience.

Your provider will monitor your response, appetite control, weight loss, side effects, and tolerability to ensure your protocol is working appropriately.

Hypospray Tirzepatide is based on transdermal delivery science, where medication is designed to absorb through the skin and enter the body over time. Published research describes transdermal drug delivery as a “non-invasive route for sustained systemic or localized drug delivery,” and research on metered spray systems has shown that certain medications can be delivered systemically through the skin.

Our Hypospray formulation of tirzepatide is designed to provide a needle-free delivery option with bioavailability intended to be comparable to injectable delivery. Your provider will monitor your response, appetite control, side effects, and weight-loss progress throughout treatment.

Hypospray uses a metered transdermal spray that is applied to the skin. The formula is designed to absorb through the skin barrier and enter the body over time.

Instead of receiving one weekly injection, patients apply their prescribed number of sprays over five separate weekday dosing days to achieve the intended weekly tirzepatide-equivalent dose.

The amount delivered per spray depends on the specific Hypospray bottle and potency prescribed by your provider. Each bottle is designed so the prescribed number of sprays used over five weekday dosing days adds up to the intended weekly tirzepatide-equivalent dose.

Your prescription will tell you exactly how many sprays to use and when to use them.

Because Hypospray Tirzepatide starts at a low dose and spreads the weekly-equivalent dose across five weekday applications, it can take a couple of weeks to build in your system.

Some patients notice appetite changes earlier, but many begin to see more noticeable weight-loss progress around week 4. Most users see peak early results around weeks 8-12 with consistent use, healthy eating, hydration, and movement.

Yes, many patients who are currently using a GLP-1 injection may be able to transition to Hypospray Tirzepatide if it is clinically appropriate. Your LaSara provider will review your current medication, current dose, last injection date, side effects, weight-loss progress, and overall treatment goals before recommending the correct Hypospray protocol.

The goal is to match your current weekly GLP-1 treatment level as closely as possible using the appropriate prescribed number of sprays over five weekday dosing days.

Yes. Hypospray Tirzepatide may be a good option for patients who have already achieved their weight-loss goal and want to maintain their results on a lower-dose protocol.

Maintenance dosing is personalized based on your appetite control, weight stability, side effects, lifestyle habits, and provider guidance. For some patients, a low-dose maintenance plan may help reduce the risk of rebound weight gain while supporting long-term appetite control and consistency.

Yes. LaSara provides physician-guided treatment and support throughout your weight-loss program. Our team helps monitor your progress, review side effects, answer questions, and guide your dose progression when appropriate.

We also encourage patients to focus on nutrition, hydration, protein intake, movement, and sustainable lifestyle habits to improve long-term results.

Common side effects of tirzepatide-based treatment may include nausea, constipation, diarrhea, reduced appetite, reflux, bloating, fatigue, or dehydration. Side effects are often most noticeable when starting treatment or increasing dose.

Your LaSara provider will help you understand what to watch for and when to contact the care team.

Yes. Tirzepatide works best when combined with a healthy diet, consistent protein intake, hydration, movement, and strength training.

Medication can help reduce appetite and cravings, but lifestyle habits help protect muscle, improve energy, support metabolism, and make results easier to maintain. The best outcomes usually come from combining medication with a realistic nutrition and fitness plan you can stick with.